SCIENCE IN Valuation
| 8D9 Stock | EUR 0.32 0.01 3.23% |
SCIENCE IN seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SCIENCE IN SPORT from analyzing the entity fundamentals such as Shares Outstanding of 172.42 M, return on asset of -0.0764, and Return On Equity of -0.29 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SCIENCE IN's price fluctuation is out of control at this time. Calculation of the real value of SCIENCE IN SPORT is based on 3 months time horizon. Increasing SCIENCE IN's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SCIENCE stock is determined by what a typical buyer is willing to pay for full or partial control of SCIENCE IN SPORT. Since SCIENCE IN is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SCIENCE Stock. However, SCIENCE IN's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.26 | Hype 0.32 | Naive 0.33 |
The real value of SCIENCE Stock, also known as its intrinsic value, is the underlying worth of SCIENCE IN SPORT Company, which is reflected in its stock price. It is based on SCIENCE IN's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SCIENCE IN's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SCIENCE IN SPORT helps investors to forecast how SCIENCE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SCIENCE IN more accurately as focusing exclusively on SCIENCE IN's fundamentals will not take into account other important factors: SCIENCE IN Total Value Analysis
SCIENCE IN SPORT is presently estimated to have takeover price of 0 with market capitalization of 25.94 M, debt of 860 K, and cash on hands of 10.47 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SCIENCE IN fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 25.94 M | 860 K | 10.47 M |
SCIENCE IN Investor Information
About 94.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.06. SCIENCE IN SPORT had not issued any dividends in recent years. Based on the analysis of SCIENCE IN's profitability, liquidity, and operating efficiency, SCIENCE IN SPORT is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.SCIENCE IN Asset Utilization
One of the ways to look at asset utilization of SCIENCE is to check how much profit was generated for every dollar of assets it reports. SCIENCE IN SPORT has a negative utilization of assets of -0.0764 %, losing €7.64E-4 for each euro of assets held by the entity. Ineffective asset utilization indicates the company is being less capable with each euro of assets it has. In other words, asset utilization of SCIENCE IN SPORT shows how unsuccessful it operates for each euro spent on its assets.SCIENCE IN Ownership Allocation
SCIENCE IN SPORT shows a total of 172.42 Million outstanding shares. The majority of SCIENCE IN SPORT outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in SCIENCE IN to benefit from reduced commissions. Thus, institutions are subject to a different set of regulations than regular investors in SCIENCE IN SPORT. Please pay attention to any change in the institutional holdings of SCIENCE IN SPORT as this could imply that something significant has changed or is about to change at the company. Also note that roughly two hundred six thousand nine hundred four invesors are currently shorting SCIENCE IN expressing very little confidence in its future performance.SCIENCE IN Profitability Analysis
The company reported the revenue of 65.55 M. Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 31.35 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SCIENCE IN's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SCIENCE IN and how it compares across the competition.
About SCIENCE IN Valuation
The stock valuation mechanism determines SCIENCE IN's current worth on a weekly basis. Our valuation model uses a comparative analysis of SCIENCE IN. We calculate exposure to SCIENCE IN's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SCIENCE IN's related companies.Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom. SCIENCE IN is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct SCIENCE IN's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SCIENCE IN's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SCIENCE IN's valuation analysis, follow these 8 steps:- Gather financial information: Obtain SCIENCE IN's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine SCIENCE IN's revenue streams: Identify SCIENCE IN's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research SCIENCE IN's industry and market trends, including the size of the market, growth rate, and competition.
- Establish SCIENCE IN's growth potential: Evaluate SCIENCE IN's management, business model, and growth potential.
- Determine SCIENCE IN's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SCIENCE IN's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for SCIENCE Stock analysis
When running SCIENCE IN's price analysis, check to measure SCIENCE IN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCIENCE IN is operating at the current time. Most of SCIENCE IN's value examination focuses on studying past and present price action to predict the probability of SCIENCE IN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCIENCE IN's price. Additionally, you may evaluate how the addition of SCIENCE IN to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |